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ABSTRACT 
Formulation F5, F6, F7 and F8 were selected to make the tablets because of their high percentage release (more than 90%). 500 mg 
weight of tablets containing 120 mg strength of Diltiazem hydrochloride were prepared from formulations F5, F6, F7 and F8.  release 
of Diltiazem hydrochloride at different interval of time: 1 hr, 4 hrs, 8 hrs and 12 hrs for different formulations, it can be concluded 
that more than 90% of Diltiazem hydrochloride was released from formulations F1, F3, F5, F6, F7, F8, F9, F11 at 12 hours. After 
compaction into the tableted form, the dissolution or release of the drug will reduce.  Hence, these formulations may be compressed 
into the tablet forms so that the release should be around or more than 80%. Some analytical definitions of the Q(t) function are 
commonly used, such as zero order, first order, Higuchi, Korsmeyer-Peppas, Hixson-Crowell models, Weibull model, Baker – 
Lonsdale model, Hopfenberg model, etc. These models are used to characterize drug dissolution/release profiles. 
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INTRODUCTION 
The concept of drug delivery has been revolutionized 
with the advancement in drug delivery systems, 
especially those offering a sustained and controlled 
action of drug to desired area of effect
1
. 
Microsponges are polymeric delivery systems composed 
of porous microspheres. They are tiny sponge-like 
spherical particles with a large porous surface. 
Moreover, they may enhance stability, reduce side 
effects and modify drug release favorably.  
The term microparticles refer to a particle with a 
diameter of 1-1000µm, irrespective of the precise 
interior or exterior structure.
 2 
Microsponges are 
polymeric delivery systems composed of porous 
microspheres. They are tiny sponge-like spherical 
particles with a large porous surface. Moreover, they 
may enhance stability, reduce side effects and modify 
drug release favorably
3
.  
Microspheres usually have diffusion controlled release 
profiles with a permanent release rate that is controlled 
kinetically by the particle size, whereas microcapsules 
usually have diffusion or dissolution controlled release 
profiles or both. Microcapsules expel their content by a 
single high burst as the shell breaks or slow releases. 
 
Figure 1: microsphere 
Hard gelatin capsules are very elegant dosage forms, but 
have the disadvantages of higher production cost, lower 
Gupta et al                                                                                                              Journal of Drug Delivery & Therapeutics. 2018; 8(1):57-63                     
ISSN: 2250-1177                                                                               [58]                                                                              CODEN (USA): JDDTAO 
production rate and tampering potential when compared 
to compressed tablets.  Microspheres have been tableted 
to control or modify the release of the drug. The tablet 
manufacturing process from microspheres will create a 
single unit from a multi-particulate system in order to 
produce compact forms that disintegrate into many 
subunits soon after ingestion to attain more uniform 
concentrations of the drug in the body.  Reduced risk of 
tampering, higher dose strength per unit and higher 
production rate of the tablet process can be listed among 
the advantages of tabletting
4
 
METHODS 
Optimization of below given formulation: 
 
Table 1: Formulations of Diltiazem hydrochloride loaded Microspheres prepared with different Polymers and 
Polymer mixtures (Drug: Polymer =1:1) 
Contents of Formulations F1 F2 F3 F4 F5 F6 F7 F8 
Diltiazem hydrochloride(gm) 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 
Eudragit RL 100 (gm) 2.0 - - - 1.0 - 1.0 - 
Eudragit RS 100 (gm) - 2.0 - - 1.0 - - 1.0 
Eudragit RLPO (gm) - - 2.0 - - 1.0 - 1.0 
Eudragit RSPO (gm) - - - 2.0 - 1.0 1.0 - 
Magnesium Stearate (gm) 
(Dispersing Agent) 
0.300 0.300 0.300 0.300 0.300 0.300 0.300 0.300 
Methanol (ml) 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 
Acetone (ml) 7.0 7.0 7.0 7.0 7.0 7.0 7.0 7.0 
Liquid paraffin (ml) 100 100 100 100 100 100 100 100 
Drug : Polymer 1: 1 1: 1 1: 1 1: 1 1: 1 1: 1 1:1 1: 1 
Magnesium Stearate (%) 3 3 3 3 3 3 3 3 
 
Table 2: Formulations of Diltiazem hydrochloride loaded Microspheres prepared with different    Polymers and 
Polymer mixtures (Drug: Polymer =1:2) 
Contents of Formulations F9 F10 F11 F12 F13 F14 F15 F16 
Diltiazem hydrochloride (gm) 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 
Eudragit RL 100 (gm) 4.0 - - - 2.0 - 2.0 - 
Eudragit RS 100 (gm) - 4.0 - - 2.0 - - 2.0 
Eudragit RLPO (gm) - - 4.0 - - 2.0 - 2.0 
Eudragit RSPO (gm) - - - 4.0 - 2.0 2.0 - 
Magnesium Stearate (gm) 
(Dispersing Agent) 
0.600 0.600 0.600 0.600 0.600 0.600 0.600 0.600 
Methanol (ml) 6.0 6.0 6.0 6.0 6.0 6.0 6.0 6.0 
Acetone (ml) 14.0 14.0 14.0 14.0 14.0 14.0 14.0 14.0 
Liquid paraffin (ml) 200 200 200 200 200 200 200 200 
Drug : Polymer 1: 2 1: 2 1: 2 1: 2 1: 2 1: 2 1: 2 1: 2 
Magnesium Stearate (%) 3 3 3 3 3 3 3 3 
 
Optimization of release rate 
After observing the release of Diltiazem hydrochloride 
at different interval of time: 1 hr, 4 hrs, 8 hrs and 12 hrs 
for different formulations, it can be concluded that more 
than 90% of Diltiazem hydrochloride was released from 
formulations F1, F3, F5, F6, F7, F8, F9, F11 at 12 hours.
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After compaction into the tableted form, the dissolution 
or release of the drug will reduce.  Hence, these 
formulations may be compressed into the tablet forms so 
that the release should be around or more than 80%.  
Co-relation between particle size and in-vitro release 
The particle size in mean diameters along with their 
cumulative percent release is tabulated below; 
 
Table 3: Correlation between mean particle size and in-vitro release of microspheres 
Formulation Drug: Polymer ratio 
Mean Particle size 
(m) 
Cumulative % Drug  
released at 12 hrs 
F5 
F6 
F7 
F8 
1: 1 
243.75 
230.25 
206.00 
212.25 
93.85 
94.98 
94.24 
97.53 
F13 
F14 
F15 
F16 
1: 2 
354.75 
359.00 
370.75 
334.00 
72.75 
66.23 
66.72 
67.41 
 
Hence from the above result, it can be concluded that as 
the particle size of the microspheres increased, the 
release rate of Diltiazem hydrochloride decreased. 
Hence, particle size of microsphere is inversely 
proportional to the release of drug from microspheres. It 
can be explained on the basis, that as the polymer 
amount increases, the matrix wall of microspheres 
become thicker. The formation of a thick wall lead to 
slower dissolution rate of drug caused by longer 
diffusional path. 
Tableting of Microspheres 
Formulation F5, F6, F7 and F8 were selected to make the 
tablets because of their high percentage release (more 
than 90%).  500 mg weight of tablets containing 120 mg 
strength of Diltiazem hydrochloride was prepared from 
formulations F5, F6, F7 and F8.  Microspheres along with 
excipients - lactose monohydrate, microcrystalline 
cellulose and sodium starch glycolate as disintegrant 
were compressed into tablets using single stroke tablet 
machine. 
In – vitro Dissolution of tableted microspheres 
Compaction of drug loaded microparticulate powders 
into tablets have been reported as useful therapeutic 
approach for oral administration of controlled release 
formulations. With respect to free powder, tablets can 
give more reproducible drug delivery and 
biopharmaceutical response, as well as a better patient 
compliance. 
The release data of Diltiazem hydrochloride from 
tableted microspheres are shown in Figure.  The in-vitro 
release profile of tableted microspheres indicated that 
the release of the drug was slow than that of 
microspheres.  The release increased gradually and up to 
12 hrs, more than 85% of drug was into the medium 
from tableted formulations (TF5, TF6, TF7 and TF8).  As 
the initial burst release of drug was observed in 
microspheres (F5, F6, F7 and F8).  However, tableting of 
the microparticulate systems can overcome the 
disadvantage of such initial large ‘burst’ release. 
 
Table 4: Cumulative release of Diltiazem hydrochloride from tableted microsphere 
 
The dissolution profiles of Formulation TabF5, TabF6, TabF7, and TabF8 were analyzed statistically by ANOVA. 
Table 5: Comparison of dissolution profiles of Formulation TabF5, TabF6, TabF7, and TabF8 using one way 
ANOVA 
Formulations 
Calculated values of ‘F’ 
Table value 
(F 0.05)* 
1
st
 hour 4
th
 hour 8
th
 hour 12
th
 hour 
4.0662 
TabF5, TabF6, TabF7, and TabF8 2.136 1.928 2.025 2.632 
* D.F. = Degree of freedom = (3, 8) 
Formulation Composition 
Drug: 
Polymer 
Ratio 
Cumulative % Release of Diltiazem hydrochloride 
1 hrs 4 hrs 8 hrs 12 hrs 
Tab F5 
RL100 : 
RS100 
1: 1 
5.16 25.53 65.28 91.18 
Tab F6 RLPO : RSPO 6.94 30.10 61.59 88.18 
Tab F7 RL100 : RSPO 5.92 27.93 63.43 89.59 
Tab F8 RS100 : RLPO 8.08 32.11 66.31 86.35 
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From the ANOVA test it was found that there was no 
significant difference among the Formulation TabF5, 
TabF6, TabF7, and TabF8 at the time of 1 hr, 4 hr, 8 hr 
and 12 hr. This is because all the tablets contained the 
microspheres of combination of Eudragit RL and RS – 
type.  
Comparison of In–vitro Dissolution of microspheres 
and tableted microspheres 
The dissolution profiles of microspheres and tableted 
microspheres were analyzed statistically by student-t 
test.
 
Table 6: Comparison of dissolution profiles of microspheres and tableted microspheres using student-t test 
Formulations 
Calculated values of ‘t’ 
Table value 
(t 0.05,)* 
1
st
 hour 4
th
 hour 8
th
 hour 12
th
 hour  
 
 
 
2.132 
F5 – TabF5 5.328 14.79 1.440 2.023 
F6 – TabF6 4.345 13.784 1.687 1.973 
F7 – TabF7 7.750 19.528 1.878 1.118 
F8 – TabF8 5.161 16.81 1.940 1.312 
* D.F. = Degree of freedom = 4 
From the student-t test it was found that there was a 
significant difference between dissolution profiles of 
microspheres and tableted microspheres from 1-4 hours. 
But there was not any significant difference between 
these for the 8-12 hours. 
Two reasons can be attributed to this reason: 
First, tableting of microspheres reduces the initial burst 
release of the drug from the formulation. 
Second, it is clear from the mathematical models, that 
the release of Diltiazem hydrochloride from 
microspheres F5 – F8 follows anomalous transport (n= 
between 0.5 – 1.0 for Peppas model, that corresponds to 
diffusion, erosion and swelling mechanism or mixed 
order kinetics). Whereas, formulation TabF6 and Tab F8 
follow zero order kinetics (n≈ 1 for Peppas model), and 
formulation TabF5 and TabF7 follow case – II transport 
(n>1 for Peppas model, that correspond to erosion and 
relaxation of swollen polymer). So, there is significant 
difference from the student-t test it was found that there 
was a significant difference between dissolution profiles 
of microspheres and tableted microspheres from 1-4 
hours. 
Mathematical model: 
5
 
Several theories and kinetic models describe the 
dissolution of drug from immediate release and 
modified release dosage forms. There are several models 
to represent the drug dissolution profiles where f(t) is a 
function of time related to the amount of drug dissolved 
from the pharmaceutical dosage form. 
The quantitative interpretation of the values obtained in 
the dissolution assay is facilitated by the usage of 
generic equation that translates the dissolution curve, 
function of some parameters related with the 
pharmaceutical dosage forms. Drug dissolved from solid 
dosage forms has been described by kinetic models in 
which the dissolved amount of drug (Q) is a function of 
the test time, t or Q(t). Some analytical definitions of the 
Q(t) function are commonly used, such as zero order, 
first order, Higuchi, Korsmeyer-Peppas, Hixson-Crowell 
models, Weibull model, Baker – Lonsdale model, 
Hopfenberg model, etc. These models are used to 
characterize drug dissolution/release profiles.   
(a) Zero Order Kinetics 
This model represents an ideal release profile in order to 
achieve the pharmacological prolonged action. Zero 
order release constitutes drug release from the dosage 
form that is independent of the amount of drug in the 
delivery system (that is, a constant release rate). 
The following equation is used to express the model: 
Qt = Qo + Kot 
Where Qt is the amount of drug dissolved in time t 
Qo is the initial amount of drug in the solution 
Ko is the zero order release constant 
For practical purposes the equation is rearranged: 
Percent drug released = Kt 
This is applicable to dosage forms like transdermal 
systems, coated dosage forms, osmotic systems as well 
as matrix tablets with low soluble drugs. 
(b) First Order Kinetics 
     First order release constitutes drug release in a way 
that is proportional to the amount of drug remaining in 
its interior; in such a way that amount of drug released 
by unit time diminish. 
The following equation is used to express the model: 
log Qt = log Qo + Kt/2.303 
Where Qt is the amount of drug dissolved in time t 
Qo is the initial amount of drug in the solution 
                 K is the first order release constant 
 For practical purposes the equation is rearranged: 
log % of drug unreleased = Kt/2.303 
 This model is applicable to dosage forms such as those 
containing water-soluble drugs in porous matrices.  
(c) Higuchi Model 
Higuchi describes drug release as a diffusion process 
based in Fick’s law, square root dependent. 
The following equation is used to express the model: 
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Qt = Kht
1/2
 
Where Qt is the amount of drug dissolved in time t 
Kh is the first order release constant 
For practical purposes the equation is rearranged: 
Percent drug released = Kt
1/2 
This model is applicable to systems with drug dispersed 
in uniform swellable polymer matrix as in case of matrix 
tablets with water soluble drugs. 
(d) Korsmeyer - Peppas Model 
This model is widely used when the release mechanism 
is not well known or when more than one type of release 
phenomenon could be involved   
The following equation is used to express the model 
Qt/Q∞ = Kt
n
 
Where Qt is the amount of drug dissolved in time t 
Q∞ is the amount of drug dissolved in infinite time  
n is the release exponent indicative of drug release 
mechanism 
K is the kinetic constant 
For practical purposes the equation is rearranged  
Log percent drug released = log K + n log t 
Peppas used n value in order to characterize different 
release mechanism concluding for values of n = 0.5 for 
Fickian diffusion and values of n, between 0.5 to 1.0 for 
anomalous transport (corresponds to diffusion, erosion 
and swelling mechanism or mixed order kinetics) and 
higher values of n, n=1 (zero order release) or n>1 for 
case-II transport (corresponds to erosion and relaxation 
of swollen polymer layer).   
(e) Hixson – Crowell Model 
Hixson and Crowel recognizing that the particle regular 
area is proportional to the cubic root of its volume, 
derived an equation that can be described in the 
following manner: 
(W0)
1/3 – (Wt)
1/3
 = Ks t 
Where: W0  - is the initial amount of drug in the dosage 
form 
Wt  - is the remaining amount of drug in the dosage 
form at time t 
Ks  - is a constant incorporating the surface- volume 
relationship 
For practical purposes the equation is rearranged  
(% Drug Unreleased)
1/3
 = Kt 
This model has been used to describe the release profile 
keeping in mind the diminishing surface of the drug 
particles during the dissolution. After fitting into these 
models, the selection was based on the comparison of 
higher determination coefficient (r
2
).
 
Table 7 (i): Descriptive statistics of regression and other parameters of the mathematical models for the 
dissolution data of formulations F1 – F8 
Model Statistics F1 F2 F3 F4 F5 F6 F7 F8 
 
Zero 
Order 
r
 2 
p 
slope 
K 
0.7793 
<0.01 
9.0430 
9.0430 
0.9280 
<0.001 
4.5115 
4.5115 
0.7851 
<0.01 
9.0159 
9.0159 
0.9007 
<0.001 
4.5087 
4.5087 
0.9157 
<0.001 
7.3090 
7.3090 
0.8817 
<0.001 
7.2048 
7.2048 
0.9085 
<0.001 
7.0346 
7.0346 
0.8542 
<0.001 
6.9798 
6.9797 
 
First 
Order 
 
r
 2 
p 
slope 
K 
0.9197 
<0.001 
-0.2115 
0.4871 
0.9747 
<0.001 
-0.0332 
0.0765 
0.9518 
<0.001 
-0.1853 
0.4268 
0.9598 
<0.001 
-0.0343 
0.0790 
0.9934 
<0.001 
-0.0983 
0.2264 
0.9972 
<0.001 
-0.1059 
0.2439 
0.9880 
<0.001 
-0.0984 
0.2266 
0.9697 
<0.001 
-0.1183 
0.2725 
 
Higuchi 
Model 
 
r
 2 
p 
slope 
K 
0.9590 
<0.001 
32.777 
32.777 
0.9914 
<0.001 
18.017 
18.017 
0.9619 
<0.001 
32.610 
32.610 
0.9854 
<0.001 
18.221 
18.221 
0.9888 
<0.001 
29.346 
29.346 
0.9839 
<0.001 
29.406 
29.406 
0.9951 
<0.001 
28.445 
28.445 
0.9807 
<0.001 
28.895 
28.895 
 
Peppas 
Model 
 
r
 2 
p 
n 
K 
0.9604 
<0.001 
0.3810 
45.384 
0.9894 
<0.001 
0.4773 
18.858 
0.9644 
<0.001 
0.3845 
44.679 
0.9795 
<0.001 
0.4485 
20.951 
0.9764 
<0.001 
0.6427 
21.009 
0.9660 
<0.001 
0.5884 
24.536 
0.9863 
<0.001 
0.5525 
25.416 
0.9576 
<0.001 
0.5180 
29.174 
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Table 7 (ii): Descriptive statistics of regression and other parameters of the mathematical models for the 
dissolution data of formulations F9 – F16 
Model Statistics F9 F10 F11 F12 F13 F14 F15 F16 
 
Zero 
Order 
 
r
 2 
p 
slope 
K 
0.8631 
<0.001 
6.6277 
6.6277 
0.9623 
<0.001 
4.0604 
4.0604 
0.8234 
<0.001 
6.7626 
6.7626 
0.9589 
<0.001 
4.2313 
4.2313 
0.9891 
<0.001 
5.5202 
5.5202 
0.9823 
<0.001 
4.8933 
4.8933 
0.9957 
<0.001 
5.1454 
5.1454 
0.9898 
<0.001 
5.1415 
5.1415 
 
First 
Order 
 
r
 2 
p 
slope 
K 
0.9957 
<0.001 
-0.0848 
0.1953 
0.9878 
<0.001 
-0.0265 
0.0610 
0.9952 
<0.001 
-0.1004 
0.2312 
0.9899 
<0.001 
-0.0281 
0.0647 
0.9459 
<0.001 
-0.0415 
0.0956 
0.9759 
<0.001 
-0.0349 
0.0804 
0.9656 
<0.001 
-0.0358 
0.0825 
0.9786 
<0.001 
-0.0370 
0.0852 
 
Higuchi 
Model 
 
r
 2 
p 
slope 
K 
0.9838 
<0.001 
27.339 
27.339 
0.9821 
<0.001 
15.849 
15.849 
0.9674 
<0.001 
28.320 
28.320 
0.9897 
<0.001 
16.609 
16.609 
0.9280 
<0.001 
20.660 
20.660 
0.9645 
<0.001 
18.734 
18.734 
0.9321 
<0.001 
19.244 
19.244 
0.9584 
<0.001 
19.548 
19.548 
 
Peppas 
Model 
 
r
 2 
p 
n 
K 
0.9632 
<0.001 
0.5223 
27.146 
0.9687 
<0.001 
0.5325 
13.807 
0.9402 
<0.001 
0.5098 
29.655 
0.9898 
<0.001 
0.5584 
13.782 
0.9796 
<0.001 
0.7326 
10.371 
0.9877 
<0.001 
0.6337 
12.451 
0.9866 
<0.001 
0.7793 
8.640 
0.9916 
<0.001 
0.6931 
11.138 
* For Zero order, First order, Higuchi Model:n= 13 (For formulation F2, F4 – F16)   n= 10 (For formulation F1, F3) 
# For Peppas Model: n= 12 (For formulation F2, F4 – F16)   n= 9 (For formulation F1, F3) 
Table 7(iii): Descriptive statistics of regression and other parameters of the mathematical models for the 
dissolution data of formulations TabF5 – TabF8 
Model Statistics TF5 TF6 TF7 TF8 
 
Zero 
Order 
 
r
 2 
p 
slope 
K 
0.9920 
<0.001 
8.2379 
8.2379 
0.9966 
<0.001 
7.6144 
7.6144 
0.9953 
<0.001 
7.9275 
7.9275 
0.9884 
<0.001 
7.4613 
7.4613 
 
First 
Order 
 
r
 2 
p 
slope 
K 
0.9263 
<0.001 
-0.0850 
0.1958 
0.9472 
<0.001 
-0.0739 
0.1702 
0.9377 
<0.001 
-0.0787 
0.1813 
0.9732 
<0.001 
-0.0707 
0.1628 
 
Higuchi 
Model 
 
r
 2 
p 
slope 
K 
0.8962 
<0.001 
30.253 
30.253 
0.9275 
<0.001 
28.381 
28.381 
0.9112 
<0.001 
29.307 
29.307 
0.9402 
<0.001 
28.113 
28.113 
 
Peppas 
Model 
 
r
 2 
p 
n 
K 
0.9966 
<0.001 
1.2059 
4.993 
0.9979 
<0.001 
1.0423 
7.036 
0.9972 
<0.001 
1.1328 
5.800 
0.9942 
<0.001 
0.9885 
9.867 
* For Zero order, First order, Higuchi, Model:   n= 13 (For formulation TF5 – TF8) 
# For Peppas Model: n= 12 (For formulation TF5 – TF8) 
Accelerated stability study 
Formulations F5, F6, F7 and F8 were stored in glass 
bottle, after wrapping with aluminium foil, at 40
o
C in 
humidity controlled oven for 3 periods of months.  It 
was observed that there was no change in the 
morphology of microspheres, as well as no 
agglomerates were formed.  The percentage residual 
drug content of microspheres were found to be 98.86% 
for F5; 98.65% for F6; 98.72% for F7 and 98.36% for F8 
after storage for 3 months as compared to initial 100% 
content
.
 
CONCLUSION 
It is observed from the table that the determination co-
efficient (r
2
) of formulations F2, F4 – F16 and TabF5 – 
TabF8 was significant for zero-order. Similarly, the 
determination co-efficient (r
2
) of formulations F1-F16 
and TabF5-TabF8 for first order kinetics was also 
showing the significant correlation. 
For Higuchi model, the determination co-efficient (r
2
) of 
formulations F1-F16 and TabF5-TabF8 are significant. 
Hence, all were following Higuchi model. 
Peppas model is used when the release mechanism is not 
well known or when more than one type of release 
phenomenon could be involved. It indicates the 
diffusional release mechanisms from polymeric films. 
The determination co-efficient (r
2
) of formulations F1-
F16 and TabF5-TabF8 are significant.  
Here, in case of formulations F5-F8, the value of n was 
between 0.5-1.0, indicating release kinetics involves 
anomalous transport (that corresponds to diffusion, 
erosion and swelling mechanism or mixed order 
kinetics). Also for formulations TF5 and TF7, the value 
of n was >1, indicating that the release kinetics followed 
case – II transport (corresponds to erosion and 
relaxation of swollen polymer). 
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But for formulation TF6 and TF8, the value of n is ≈ 1, 
indicating that the release kinetics followed zero – order 
release. 
Also the value of r
2
 for TF5, TF6, TF7 and TF8 are 
maximum for zero order (among zero order, first order 
and Higuchi model), indicating that the release of 
Diltiazem hydrochloride from these tablets followed 
zero order kinetics. 
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